What Is Methylation? The Biochemical Process Explained
Methylation is the transfer of a single carbon group, and it runs DNA regulation, neurotransmitter turnover and detoxification. What it is, and what MTHFR does not mean.
The Short Answer
Methylation is the transfer of a single carbon atom with three hydrogens, a methyl group, from one molecule to another, and it is one of the most frequent chemical reactions in human biochemistry. Nearly all of it uses the same donor, S-adenosylmethionine, usually abbreviated SAMe, and the reactions it powers include silencing of gene expression through DNA methylation, synthesis and breakdown of adrenaline, dopamine and melatonin, production of creatine and phosphatidylcholine, and phase II detoxification of several compound classes. The nutrients that sustain the cycle are folate, vitamin B12, vitamin B6, riboflavin, choline, betaine and methionine, and the cycle's central intermediate, homocysteine, is the marker most often used to assess whether it is running well.
The Cycle in Plain Terms
One-carbon metabolism is easier to follow as a loop with three connected sections.
Making the donor. Methionine, from dietary protein, is activated to SAMe using ATP. SAMe is the universal methyl donor and it hands its methyl group to hundreds of different acceptors.
Spending it. Once SAMe donates its methyl group it becomes S-adenosylhomocysteine, which is hydrolysed to homocysteine and adenosine. The ratio of SAMe to S-adenosylhomocysteine, rather than the absolute level of either, is what determines whether methyltransferase enzymes can work, since the product inhibits them.
Recovering or disposing of homocysteine. Three routes exist. Remethylation back to methionine using a methyl group from 5-methyltetrahydrofolate, catalysed by methionine synthase and requiring vitamin B12. Remethylation using betaine, from choline, through a route concentrated in liver and kidney. Or the transsulfuration pathway, which commits homocysteine irreversibly to cysteine and then glutathione synthesis, requiring vitamin B6.
The folate side feeds the first route: dietary folate or supplemental folic acid must be reduced and then converted by MTHFR, methylenetetrahydrofolate reductase, into the 5-methyltetrahydrofolate that donates the methyl group. Riboflavin is the cofactor for that enzyme, which is why B2 status matters more than most people expect.
What Methylation Actually Does
- Gene regulation. DNA methyltransferases add methyl groups to cytosine bases, generally reducing transcription of the affected gene. This is the substrate of epigenetics and the basis of every epigenetic clock.
- Neurotransmitter turnover. Catechol-O-methyltransferase inactivates dopamine, adrenaline and noradrenaline by methylating them. Methylation also converts noradrenaline to adrenaline and serotonin to melatonin.
- Creatine synthesis. A large share of the body's total methylation output goes into making creatine, which is one reason creatine supplementation lowers homocysteine modestly: it removes a demand from the cycle.
- Phospholipid synthesis. Phosphatidylethanolamine is methylated three times to make phosphatidylcholine, another major consumer of methyl groups and a route that links methylation to liver fat handling.
- Detoxification and histamine. Histamine N-methyltransferase is one of the two routes for histamine breakdown, and several xenobiotics are methylated in phase II conjugation.
- Protein and RNA modification. Histone methylation, arginine methylation of signalling proteins, and RNA methylation all regulate function.
The scale is worth noting: creatine synthesis and phosphatidylcholine synthesis together account for the majority of methyl group consumption, which means the cycle is dominated by structural biochemistry rather than by gene regulation.
Homocysteine as the Readout
Homocysteine sits at the junction of all three disposal routes, so it rises when any of them is constrained. That makes it a sensitive and non-specific marker.
Elevation points to low folate, low B12, low B6, low riboflavin, impaired kidney clearance, hypothyroidism, certain medications including methotrexate and some anticonvulsants, high alcohol intake, or genetic variation in the enzymes. It does not identify which, which is why an elevated value is a prompt to check the inputs rather than a finding in itself.
Interpretation has a well-known complication. Elevated homocysteine associates robustly with cardiovascular events, stroke and cognitive decline in observational data, and large trials lowering it with B vitamins have not reduced cardiovascular events. The effect on stroke is more favourable than on cardiac endpoints, and trials in cognitive decline have shown benefit mainly in subgroups with low B12 status or with adequate omega-3 intake. The most reasonable reading is that homocysteine is partly a marker of an underlying state rather than solely a cause, and that lowering it matters most where the cause is a nutrient shortfall.
Practically: a value above roughly 10 to 12 micromoles per litre warrants looking at B12, folate and B6 status. Very high values, above 30, warrant clinical assessment, since inherited enzyme defects and B12 malabsorption both present that way.
MTHFR, and What It Does Not Mean
MTHFR variants are the most over-interpreted genetic finding in consumer wellness, and the correction is worth stating carefully.
What is true. The C677T variant reduces enzyme activity, by roughly thirty percent in heterozygotes and sixty to seventy percent in homozygotes. Homozygotes have modestly higher average homocysteine, and the effect is largely abolished when folate and riboflavin intake are adequate. The variant is common, with homozygosity in roughly ten percent of many populations, which by itself argues against a large individual effect.
What is not established. That the variant requires methylfolate supplementation rather than adequate folate intake. That it explains fatigue, mood symptoms, anxiety or a wide range of unrelated complaints. That it makes folic acid harmful. That it warrants high-dose methylfolate, which in some people produces agitation and sleep disruption. Large-scale association studies have not supported the broad clinical picture built around this variant.
The reasonable position. Adequate folate from food, adequate riboflavin, and confirmed B12 status handle the variant in nearly everyone. Methylated forms are a sensible choice for people who prefer them and are not a general upgrade. A homocysteine measurement is more informative than the genotype, because it reports the outcome rather than one input to it.
Supporting the Cycle Sensibly
The nutrients, in order of how often they are the constraint. B12 first, because shortfall is common in older adults, in vegetarians and vegans, and in anyone on long-term metformin or acid suppression, and because it is the one whose neurological consequences are not fully reversible if left long enough. Folate from leafy greens, legumes and liver, with fortified sources in many countries. Riboflavin, frequently overlooked and the MTHFR cofactor. B6 from a wide range of foods. Choline, where intake is below adequate in a large share of the population, particularly in those eating few eggs.
What reduces demand. Creatine supplementation removes a large methylation demand and lowers homocysteine modestly. Adequate choline spares methyl groups by allowing the betaine route.
What raises demand or impairs the cycle. High alcohol intake, which interferes at several points. Very high methionine intake without adequate B vitamins. Smoking. Some medications, notably methotrexate, certain anticonvulsants, and long-term metformin and proton pump inhibitors through B12.
The caution. More is not better. Folic acid at high doses can mask B12 shortfall while neurological consequences progress, which is the reason B12 should be confirmed before folate is pushed. High-dose methylfolate is poorly tolerated by some people. And methylation is a regulated system, not a throughput to be maximised: the objective is a cycle that runs adequately, not one driven as hard as supplementation permits.
The AEONNN Perspective
Methylation sits under Cellular Energy and Repair, Pillar 1, with direct relevance to Cognition and Neuroprotection, Pillar 5, and it is a good illustration of why AEONNN reasons from a measured outcome rather than from a genotype where both are available.
Homocysteine is the outcome; MTHFR genotype is one input among several to it. A platform that recommended methylfolate from a genotype alone would be acting on less information than a single blood value provides, and would miss the more common constraints, which are B12 status, riboflavin and choline intake. The Evidence layer records that the broad clinical picture built around MTHFR variants is not supported at scale, and the Mechanistic layer explains why the variant's effect largely disappears when folate and riboflavin are adequate.
The Safety layer carries the ordering constraint that matters most here: B12 status is confirmed before folate is raised, because high folate intake can mask a B12 shortfall while its neurological consequences continue. That is a sequencing rule rather than a dose rule, and sequencing is exactly what Insight Protocol exists to specify.
Pillar Matrix mapping
Database Matrix layers
- Mechanistic Layer (KEGG, Reactome, UniProt)
- Evidence Layer (PubMed, Cochrane, ClinicalTrials.gov)
- Meta / Consensus Layer (JAMA, BMJ, specialty society positions)
- Safety Layer (DrugBank, FAERS)
Frequently Asked
What is methylation in simple terms?
The transfer of a small chemical group, one carbon with three hydrogens, from one molecule to another. It is one of the most common reactions in the body and it powers gene silencing, neurotransmitter breakdown, creatine synthesis and parts of detoxification.
What nutrients does methylation need?
Folate, vitamin B12, vitamin B6, riboflavin, choline, betaine and methionine. B12 is most often the limiting one, particularly in older adults, vegetarians and vegans, and people on long-term metformin or acid suppression.
What is homocysteine and why does it matter?
An intermediate that sits at the junction of the cycle’s three disposal routes, so it rises when any of them is constrained. It is a sensitive but non-specific marker: an elevated value indicates something in the cycle is limited without identifying what.
Should I lower my homocysteine?
Where it is elevated because of a nutrient shortfall, correcting that shortfall is worthwhile on its own terms. Large trials lowering homocysteine with B vitamins have not reduced cardiovascular events, so it appears to be partly a marker of an underlying state rather than solely a cause.
What does an MTHFR variant mean?
The common C677T variant reduces enzyme activity, by around thirty percent in heterozygotes and sixty to seventy percent in homozygotes, and raises average homocysteine modestly. The effect is largely abolished when folate and riboflavin intake are adequate.
Do I need methylfolate if I have MTHFR?
Not necessarily. Adequate folate from food, adequate riboflavin and confirmed B12 status handle the variant in nearly everyone. Methylated forms are a reasonable preference rather than a requirement, and high-dose methylfolate is poorly tolerated by some people.
Can you overdo methylation support?
Yes. High-dose folic acid can mask a B12 shortfall while neurological consequences progress, which is why B12 should be confirmed first. Methylation is a regulated system rather than a throughput to maximise.
Evidence and review
Any dosage ranges cited here reflect the ranges used in published human trials, not personal recommendations. Evidence in this field moves, so this article is reviewed quarterly and carries its last-updated date above. Nothing here is intended as medical advice, and supplementation should be discussed with a qualified clinician, particularly alongside prescribed medication or an existing condition.